Diabetic Retinopathy clinical trials
29 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema
- A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
- The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma
- Village-Integrated Eye Worker Trial II
- Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
- ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
- Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
- Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
- Assessment of AI Program 'DRISTi' as a Screening Tool
- Biomarker of Diabetic Retinopathy
- Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
- Assessment of the Ocular Microbiome in Health and Disease
- Intraoperative OCT Guidance of Intraocular Surgery II
- National Eye Institute Biorepository for Retinal Diseases
- Novel Glaucoma Diagnostics
- Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
- Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)
- Sleep, Diabetic Retinopathy and Melatonin
- Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2
- Strategies for Improving Linkage-to-Care After Eye Disease Screening
- Clinical Applications of Advanced Ophthalmic Imaging
- Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema
- Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center
- I-TRUST: Implementation of Teleophthalmology in Rural Health Systems Study
- Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy
- Treating Early Stage Diabetic Retinopathy
- Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections
- Fenofibrate for Prevention of DR Worsening
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Diabetic Retinopathy” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.